242666 ⎘
Non-hormonal steroid modulators of NF-kB for treatment of disease
#2Non-hormonal steroid modulators of NF-kB for treatment of disease
#3Non-hormonal steroid modulators of NF-kB for treatment of disease
#4Structure assessment of heterogeneous polypeptide mixture
#5Methods of modulating immunity
#6Non-hormonal steroid modulators of NF-κB for treatment of disease
#7Structure assessment of heterogeneous polypeptide mixture
#8Use of for treatment of virus infections
#9TNF-A and TWEAK dual antagonist for the prophylaxis and treatment of autoimmune diseases
#10Utilization of dialkylfumarates
#11Treatment of Neurodegenerative Diseases
#12Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#13Aminopterin Dosage Forms and Methods for Inflammatory Disorders
#14IMMUNOTHERAPY OF AUTOIMMUNE DISORDERS USING ANTIBODIES WHICH TARGET B-CELLS
#1511a, 12-derivatives of tetracycline compounds
#16Non-hormonal steroid modulators of NF-κB for treatment of disease
#17Copolymer-1 improvements in compositions of copolymers
#18Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
#19IMMUNOTHERAPY OF AUTOIMMUNE DISORDERS USING ANTIBODIES WHICH TARGET B-CELLS
#20Utilization of dialkylfumarates
#21IMMUNOTHERAPY OF AUTOIMMUNE DISORDERS USING ANTIBODIES WHICH TARGET B-CELLS
#22Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders
#23Method for treating a mammal by administration of a compound having the ability to release CO
#24METHODS AND COMPOSITIONS FOR MODULATING IMMUNITY
#25Methods of Modulating Immunity
#26Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling
#27Treatment of autoimmune conditions with Copolymer 1 and related copolymers
#28Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#29Non-hormonal steroid modulators of NF-κB for treatment of disease
#30Use of for treatment of virus infections
#31METHOD OF MODULATING CELLULAR ACTIVITY AND AGENTS USEFUL FOR SAME
#32METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS
#33METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS
#34Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
#35Methods and compositions for modulating immunity
#36METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS
#37METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS
#38Use of for treatment of autoimmune diseases
#392-aminoalcohols for the treatment of neurodegenerative diseases
#40Utilization of dialkylfumarates
#41Utilization of dialkylfumarates
#42Novel 4-Dedimethylaminotetracycline derivatives
#43Glial mitogenic factors, their preparation and use
#44Therapeutically active triazoles and their use
#45Aminopterin dosage forms and methods for inflammatory disorders
#46Method of modulating cellular activity and agents useful for same
#47AMINOPTERIN DOSAGE FORMS
#482-ethyl and 2-ethylidene-19-nor-vitamin D compounds
#49N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines
#50Utilization of dialkylfumarates
#51Utilization of dialkylfumarates
#52Method for producing polyol-IFN-β conjugate
#53Copolymer-1 improvements in compositions of copolymers
#542-ethyl and 2-ethylidene-19-nor-vitamin D compounds
#55Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#56Treatment of autoimmune conditions with Copolymer 1 and related Copolymers
#57IMMUNOTHERAPY OF AUTOIMMUNE DISORDERS USING ANTIBODIES WHICH TARGET B-CELLS
#58Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
#5911a, 12-derivatives of tetracycline compounds
#60Method for treating a mammal by administration of a compound having the ability to release CO
#61Aminopterin dosage forms and methods for inflammatory disorders
#62Method for treating ocular hypertension and glaucoma
#63Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
#64Immunotherapy of autoimmune disorders using antibodies which target B-cells
#65Use of treosulfan and derivatives thereof for treating multiple sclerosis
#66Method of treating demyelinating diseases or conditions
#672-ethyl and 2-ethylidene-19-nor-vitamin D compounds
#68Therapeutic chemokine receptor antagonists
#69Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
#70Method of treating of demyelinating diseases or conditions
#71Methods of modulating immunity
#72Immunotherapy of autoimmune disorders using antibodies which target B-cells
#73Copolymer-1 improvements in compositions of copolymers
#744-dedimethylaminotetracycline derivatives
#75Method of treating of demyelinating diseases or conditions
#76Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
#772-Ethyl and 2-ethylidene-19-nor-vitamin D compounds
#78Methods for inhibiting lymphotoxin β receptor signalling
#79Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-[1,2,4]-triazole for the treatment of autoimmune diseases